MiR-25 promotes gastric cancer cells growth and motility by targeting RECK. (Q39090032)

9 September 2017

MiR-25 promotes gastric cancer cells growth and motility by targeting RECK. (English)

1 reference

9 September 2017

Hongying Zhao

1

1 reference

9 September 2017

Yu Wang

2

1 reference

9 September 2017

Liu Yang

3

1 reference

9 September 2017

Rongke Jiang

4

1 reference

9 September 2017

Wenqing Li

5

1 reference

9 September 2017

1 January 2014

1 reference

Molecular and Cellular Biochemistry

9 September 2017

1 reference

9 September 2017

385

1 reference

9 September 2017

1-2

1 reference

9 September 2017

207-213

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1829-x

9 September 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

Melatonin attenuates scopolamine-induced memory/synaptic disorder by rescuing EPACs/miR-124/Egr1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

miR-150 promotes the proliferation of lung cancer cells by targeting P53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

miR-146a and miR-150 promote the differentiation of CD133+ cells into T-lymphoid lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

Pancreatitis-associated protein inhibits human pancreatic stellate cell MMP-1 and -2, TIMP-1 and -2 secretion and RECK expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1829-X

MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells

1 reference

12 December 2020

Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review)

1 reference

12 December 2020

MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer

1 reference

12 December 2020

MicroRNA profiling of human gastric cancer

1 reference

12 December 2020

Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK.

1 reference

12 December 2020

MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.

1 reference

12 December 2020

10.1007/S11010-013-1829-X

Identifiers

DOI

1 reference

9 September 2017

1 reference